Peptide Synthesis Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2022 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Peptide Synthesis Market: By Product & Service (Reagents, Equipment, Services), by Reagents (Resins, Amino acids, Coupling Reagents, Dyes and Fluorescent labeling reagents, Other Reagents), by Equipment (Peptide Synthesizers, Chromatography Equipment, Lyophiizers), by Technology (Solid-Phase Peptide Synthesis, Solution-Phase Peptide Synthesis, Hybrid & Recombinant Technology), by End-user (Pharmaceutical & Biotechnology companies, CDMOs & CROs, Academic & Research Institutes) and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Peptide Synthesis Market size was valued at USD 4,372.6 million in 2021 and is poised to grow at a significant CAGR of 7.7% over 2022–2028. The concept of individualized therapy with the best response and largest safety margin to assure improved patient care has driven interest in personalized treatment. Proteomic analysis is a strong and appealing method for determining the molecular profiles of various tissues, whether healthy or sick. The next step in customized medicine is personalized proteomics, also known as proteome profiling, which clarifies illness path mechanisms. Furthermore, Label-free sensors based on nanomaterials will then detect and quantify the ligand-receptor complexes. The technology will allow for the automated injection of the various reagents required for ligand synthesis, personalized and controlled peptide synthesis, and the use of proteomics in personalized medicine. The rising need for sophisticated treatments with few side effects and the increasing prevalence of diseases like cancer and cardiovascular disease drive more investment in customized therapy. Personalized medicine has the potential to improve healthcare while reducing costs. Players in the peptide synthesis market will benefit from such advancements in personalized medicine. Using peptides in the pharmaceutical and consumer healthcare industries is driving the market’s expansion. The peptides have many uses in treating malignancies, diabetes, and obesity, among other lifestyle problems. The rising prevalence of these metabolic and lifestyle diseases is opening the path for peptide therapies to be used in oncology and metabolic illnesses. According to a report published by the International Diabetes Federation in 2020, around 463 million individuals were living with diabetes in 2019, with the prevalence expected to reach 700 million by 2045. The key reason driving the need for Custom Peptide Synthesis Services is increased research and development by biotechnology and pharmaceutical businesses. The lack of time available to scientists and researchers to create their customized peptides may drive the Custom Peptide Synthesis Services market forward. Major peptide synthesis market companies may partner with smaller players to grow their market presence and raise revenue shares.

Recent Market Developments:

In August 2021, Bachem Holding AG (Switzerland) and Novo Nordisk (Denmark)collaborated to develop a greener technology for solid-phase peptide synthesis (SPPS), under which two studies were conducted to find solvent alternatives to replace the reprotoxic N, N-dimethylformamide (DMF), dichloromethane (DCM), and N-methyl-2-pyrrolidone (NMP).

Peptide Synthesis Market

MARKET SUMMARY
-
7.7%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 7.7%
  • Largest Market– Asia Pacific
  • Fastest Growing Market– North America

Peptide Synthesis Market

  • The report on global peptide synthesis market gives historical, current and future market sizes (US$ Mn) on the basis of product & services, reagents, equipment, technology, end user, and geography.
  • The peptide synthesis market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Merck KGaA
  • Bachem Holdings
  • CEM Corporation
  • Thermo Fisher
  • Creative Diagnostics
  • Polypeptide Group
Peptide Synthesis Market Dynamics

Peptides are pharmacological compounds that are both highly active and very selective. They are used in a wide range of therapeutic areas due to the diversity of their biological actions. Because of their broad chemical space, high physical activity, high specificity, relative simplicity of synthesis, accessible availability, and low toxicity, peptides are increasingly considered potential active pharmacological components in medication development. Peptides contribute billions of dollars in income in three major therapeutic areas: oncology, diabetes, and obesity. The use of peptides in treating cardiovascular and neurological illnesses, renal failure, and uncommon diseases is also rising. On the other hand, the lack of a unified set of regulations for therapeutic peptides hinders the market growth.


Europe Got Significant Share

Peptide Synthesis Market

The peptide synthesis market in Europe is likely to hold a significant revenue share in 2022, and in the following years, it is predicted to increase rapidly. The high prevalence of chronic diseases, increasing investments in the development of structure-based drug designs, growing research in genomics and proteomics, and increasing focus on developing personalized therapeutics all contribute to North America's large share of the global market. In 2020, the United States had the largest share of the North American market. The United States' substantial share is primarily due to the country's growing life science research efforts and the rising prevalence of cancer and chronic disorders.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The peptide synthesis market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Peptide Synthesis Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The peptide synthesis market is projected to expand at a CAGR of 7.7% during the forecast period

Genscript Biotech, Merck KGaA, Bachem Holdings, Biotage, CEM Corporation, MP Biomedicals, Novo Nordisk A/S.

Europe is the fastest-growing region for peptide synthesis market


Report

Company Profile

  • Genscript Biotech
  • Merck KGaA
  • Bachem Holdings
  • Biotage
  • CEM Corporation
  • Thermo Fisher
  • Creative Diagnostics
  • Polypeptide Group
  • Syngene
  • PuroSynth
  • Lonza
  • MP Biomedicals
  • Novo Nordisk A/S.

Description

Peptide Synthesis Market size was valued at USD 4,372.6 million in 2021 and is poised to grow at a significant CAGR of 7.7% over 2022–2028. The concept of individualized therapy with the best response and largest safety margin to assure improved patient care has driven interest in personalized treatment. Proteomic analysis is a strong and appealing method for determining the molecular profiles of various tissues, whether healthy or sick. The next step in customized medicine is personalized proteomics, also known as proteome profiling, which clarifies illness path mechanisms. Furthermore, Label-free sensors based on nanomaterials will then detect and quantify the ligand-receptor complexes. The technology will allow for the automated injection of the various reagents required for ligand synthesis, personalized and controlled peptide synthesis, and the use of proteomics in personalized medicine. The rising need for sophisticated treatments with few side effects and the increasing prevalence of diseases like cancer and cardiovascular disease drive more investment in customized therapy. Personalized medicine has the potential to improve healthcare while reducing costs. Players in the peptide synthesis market will benefit from such advancements in personalized medicine. Using peptides in the pharmaceutical and consumer healthcare industries is driving the market’s expansion. The peptides have many uses in treating malignancies, diabetes, and obesity, among other lifestyle problems. The rising prevalence of these metabolic and lifestyle diseases is opening the path for peptide therapies to be used in oncology and metabolic illnesses. According to a report published by the International Diabetes Federation in 2020, around 463 million individuals were living with diabetes in 2019, with the prevalence expected to reach 700 million by 2045. The key reason driving the need for Custom Peptide Synthesis Services is increased research and development by biotechnology and pharmaceutical businesses. The lack of time available to scientists and researchers to create their customized peptides may drive the Custom Peptide Synthesis Services market forward. Major peptide synthesis market companies may partner with smaller players to grow their market presence and raise revenue shares.

Recent Market Developments:

In August 2021, Bachem Holding AG (Switzerland) and Novo Nordisk (Denmark)collaborated to develop a greener technology for solid-phase peptide synthesis (SPPS), under which two studies were conducted to find solvent alternatives to replace the reprotoxic N, N-dimethylformamide (DMF), dichloromethane (DCM), and N-methyl-2-pyrrolidone (NMP).

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX